Interleukin-12 (IL-12) and interferon-g (IFN-g) exert protec-I (SAC)-
I
resistance to pathogens and reduced mortality to a septic challenge. [8] [9] [10] However, excessive doses of recombinant IL-NTERLEUKIN-12 (IL-12) and interferon-g (IFN-g) represent both potent immunoreactive mediators, which upregulate immune functions pivotal for the protection 12 appeared to decrease the resistance to a bacterial challenge after burn injury in mice. . IL-12 promotes TH1 type cytokine Critically ill patients are often anergic and show a high susceptibility to invading microorganisms through severe inresponse, enhances specific and nonspecific cytolytic lymphocyte responses, and stimulates the proliferation of actihibition of the cellular, humoral, and phagocytic immune system. [12] [13] [14] In this study, we investigated a potential downvated T lymphocytes and natural killer (NK) cells. 1 INF-g has potent microbicidal activities through upregulation of regulation of the IL-12 IFN-g pathway in critically ill patients and the underlying mechanisms using lipopolysacchamonocytes/macrophages with an increased secretion of proinflammatory cytokines. 2 Moreover, IFN-g promotes the anride (LPS)-stimulated whole blood as an ex vivo model of endotoxemia. 14 Although this system cannot completely detigen presenting process through enhanced expression of the major histocompatability complex (MHC) class II antigen. 2 pict cytokine interactions in the whole body, it has considerable relevance with respect to local compartmentalized cyto-IL-12 induces T and NK cells to produce IFN-g. 3, 4 On the other hand, IFN-g upregulates the synthesis and release of kine interactions. Additionally, it excludes any influence of cell preparation techniques on cell receptors and preserves IL-12 by phagocytic cells, B cells, and neutrophils. [5] [6] [7] The interactions between IFN-g and IL-12 appear to be involved a natural environment.
14 in a positive feedback mechanism that results in the activa-
MATERIALS AND METHODS
tion of phagocytic cells during bacterial and parasitic infec- Supernatants of lymphocyte cultures were harvested, filtered, aliGately, Hoffmann-LaRoche, Nutley, NJ) or rhIFN-g (100, 50, 10, quoted, and stored at 080ЊC until measured for IFN-g. 5, 1 ng/mL; biological activity 3 1 10 7 U/mg; endotoxin contaminaAdditionally, whole blood from healthy individuals was preincution õ0.3 EU/mg; kindly provided by Dr G.R. Adolf, Bender, Wien, bated with either IL-4 (1,000 pg/mL; biological activity 1 1 10 7 Austria). The blood containing tubes were placed on a rotator in a U/mg; Genzyme Corp, Cambridge, MA) or IL-10 (2,500 pg/mL; 5% CO 2 atmosphere at 37ЊC. At 8 hours and 24 hours of incubation, biological activity 1.5 1 10 7 U/mg; endotoxin contamination õ10 the samples were removed. Plasma was prepared through centrifuga-EU/mg; Schering-Plough Research Institute, Kenilworth, NJ) for tion with 2,100 rpm at 4ЊC, aliquoted, and stored at 080ЊC until 12 hours. Thereafter, PBMC were harvested using density gradient assayed for cytokines. In addition, whole blood from both groups centrifugation as described above, washed three times, and incubated was incubated with Staphylococcus aureus Cowan strain I (SAC; with LPS (1 ng/mL; Escherichia coli 055:B5; Sigma Chemical Co) Pansorbin; 0.075% wt/vol; Calbiochem Corp, La Jolla, CA) for 8 for 24 hours. PBMC supernatants were harvested, filtered, aliquoted, hours and 24 hours, respectively. Plasma was prepared and stored and stored at 080ЊC until assayed for cytokines. as described above.
Cytokine measurements. Levels of IFN-g in plasma and lymThe contamination of blood samples from the two groups with phocyte supernatants were measured with specific sandwich enzymeendotoxin through the added reagents was excluded using the Limulus amebocyte assay.
linked immunosorbent assay (ELISA) using the antihuman IFN-g Whole blood obtained from healthy individuals (controls, n Å 12) and critically ill patients (n Å 25) was incubated with LPS (1 ng/mL) in the presence or absence of rhIFN-g (10 ng/mL) for 8 hours and 24 hours, respectively. Plasma levels of IL-12 p40 (pg/mL) and p70 (pg/mL) were measured using specific ELISA. Data are presented as mean { SEM.
Abbreviation: ND, not detectable. * P õ .05 LPS versus LPS / rhIFN-g. † P õ .05 patient versus control.
AID Blood 0029 / 5h2f$$$561 01-29-97 01:08:11 bldal WBS: Blood monoclonal antibodies NIB42 for capture and 4S.B3 for detection (Pharmingen, San Diego, CA). Standards of rhIFN-g (Pharmingen) were diluted in normal human plasma. The ELISA showed a sensitivity of ú100 pg/mL. Concentrations of IL-12 p40 in plasma and supernatants of adherent cells were measured using the rat monoclonal anti-human IL-12 p40 antibody 2-4A1 for coating and the peroxidase-conjugated anti-IL-12 p40 antibody 4D6 for detection (antibodies and recombinant human IL-12 p40 kindly provided by Maurice K. Gately, Hoffman-LaRoche) (sensitivity ú10 pg/mL).
18
IL-12 p70 was determined with a commercially available ELISA kit (R & D Systems Inc, Minneapolis, MN) according to the manufacturer's guidelines. The ELISA uses a capture antibody that recognizes the IL-12 p70 heterodimer with a sensitivity ú5 pg/mL. IL-4 and transforming growth factor (TGF)-b 1 in plasma samples were measured using commercially available ELISA kits (Genzyme) with a sensitivity of ú30 pg/mL for IL-4 and ú50 pg/mL for TGFb 1 . For measurements of TGF-b 1 , plasma samples were acidified as previously described. 19 Without acidification, TGF-b 1 was neither detectable in plasma from healthy humans, nor in critically ill patients. IL-10 was measured in plasma by ELISA with the rat antihuman IL-10 monoclonal antibody JES3-9D7 for capture and a rabbit antihuman IL-10 polyclonal antibody for detection (antibodies kindly provided by Satwant Narula, PhD, Schering-Plough Research Institute, Kenilworth, NJ).
20 Recombinant hIL-10 (Schering-Plough) diluted in normal plasma was used for the standard curve. The ELISA showed a sensitivity of ú20 pg/mL.
All samples were tested in duplicate.
Statistics. Results are demonstrated as mean { standard error of mean (SEM). Statistical analysis was performed using nonparametric Mann-Whitney U-test with Bonferroni correction for multiple comparisons.
RESULTS

IFN-g induced release of IL-12 p40 and p70 into whole
blood. IL-12 p40 was not detectable at baseline (0 hours incubation time) in healthy individuals, while very low concentrations were found in plasma samples from critically ill patients (15.9 { 2.4 pg/mL; 7 of 25 patients [28%]). In contrast to previous studies, 21 rhIFN-g slightly enhanced the release of IL-12 p40 in both groups, though these levels reflected only 10% of those detected in the presence of rhIFN-g and LPS. Levels of IL-12 p40 in IFN-g stimulated whole blood from critically ill patients (47.1 { 11.5 pg/ mL) were significantly decreased by 73% compared with the control group (172.7 { 38.0 pg/mL). IL-12 p70 was not detectable at baseline and its secretion could not be induced through rhIFN-g in any of the two groups during an incubation period of 24 hours, which is in line with previous studies. 21, 22 In the control group, LPS in a concentration of 1 ng/mL resulted in a significant increase of IL-12 p40 at 8 hours and 24 hours of incubation compared with baseline, while only minimal levels of IL-12 p70 (10.0 { 4.5 pg/mL) were detected ( Table 2 ). The amounts of produced IL-12 p40 largely exceeded those of IL-12 p70, which is in line with previous studies.
23 Because high concentrations of 1 mg/mL LPS led p40 and p70 seem to be dependent on the LPS dosage. 23 In Whole blood obtained from healthy individuals (controls, n Å 12) and critically ill patients (n Å 25) was incubated with or without LPS (1 ng/ mL) in the presence or absence of rhIL-12 p70 (5 ng/mL) for 8 hours and 24 hours, respectively. Plasma levels of IFN-g (pg/mL) were measured using specific ELISA. Data are presented as mean { SEM. * P õ .05 without agent versus rhIL-12 p70, LPS, or LPS / rhIL-12 p70. † P õ .05 patient versus control.
The addition of rhIFN-g and LPS to whole blood from p40, p70, and IFN-g (Fig 2A through C) , which could be dramatically increased in the presence of either rhIFN-g or healthy individuals led to a significant rise in IL-12 p40 and p70 secretion at 8 hours and 24 hours with a dose-dependent rhIL-12 p70, respectively (Fig 2A through C) . In contrast, SAC-induced secretion of these three cytokines was signifieffect ( Table 2 , Fig 1A and B) . Though rhIFN-g increased the release of IL-12 p40 into whole blood from critically ill cantly suppressed in whole blood obtained from critically ill patients (Fig 2A through C) . patients, total amounts of secreted IL-12 p40 were markedly suppressed by 89% at 8 hours and 87% at 24 hours compared Secretion of IL-12 p40, p70, and IFN-g by isolated adherent cells and lymphocytes. In addition, IL-12 p40 and p70 with healthy individuals (Table 2 ). In addition, rhIFN-g did not induce secretion of IL-12 p70 into LPS-stimulated whole secretion by isolated adherent cells and IFN-g release by purified lymphocytes was determined. These experiments blood obtained from critically ill patients at any time point or with any dosage of rhIFN-g ( Table 2 , Fig 1B) . Previous give further information, whether differential leukocyte profiles on one hand and soluble suppressive factors in serum reports 5 using isolated cell cultures suggested peak levels of IL-12 p70 release after 48 hours of incubation. To exclude on the other hand, are responsible for suppression of the IL-12 IFN-g pathway in whole blood. Isolated adherent cell the possibility that IL-12 p70 release into whole blood from critically ill patients occurs after 24 hours of incubation, and lymphocyte cultures, stimulated either with LPS or with SAC, demonstrated similar suppression of IL-12 p40, p70, control studies stimulating whole blood with LPS and rhIFNg for 36 hours were performed. These studies did not demonand IFN-g release in critically ill patients compared with healthy humans (Fig 3A through C) . The addition of rhIFNstrate a further increase of IL-12 p70 release between 24 hours and 36 hours of incubation in any of the two groups g to adherent cell cultures in the presence of LPS did not only augment secretion of IL-12 p40, but also of IL-12 p70 (data not shown).
Interleukin-12 p70 induced release of IFN-g into whole in critically ill patients (Fig 3A and B) . Moreover, rhIL-12 p70 increased LPS-induced release of IFN-g by lymphocytes blood. Baseline levels (0 hours incubation time) of IFN-g were similar in both groups (controls, 263.3 { 98.2 pg/mL; from critically ill patients (Fig 3C) , which was not seen in the whole blood assay. Thus, the responsiveness to either patients, 213.2 { 52.5 pg/mL). rhIL-12 p70 in the absence of LPS resulted in a marked increase of IFN-g by 102% at rhIL-12 p70 or to rhIFN-g in the presence of a bacterial challenge seems to be increased in isolated cell cultures from 8 hours and by 105% at 24 hours of incubation in the control group, while it did not enhance secretion of IFN-g in criticritically ill patients compared with the results obtained with whole blood, though the absolute secretory capacity of adcally ill patients (Table 3) . LPS alone significantly enhanced the release of IFN-g in controls, but did not affect secretion herent cells and lymphocytes from critically ill patients is still reduced compared with healthy individuals (Fig 3A  of IFN -g in critically ill patients ( Table 3 ). The addition of rhIL-12 p70 to whole blood from healthy humans in the through C).
Release of antiinflammatory cytokines into whole blood. presence of LPS resulted in a dose-dependent and significant increase of IFN-g release at 8 hours (/338%) and 24 hours
Since cytokines such as IL-4, IL-10, TGF-b 1 have been found to inhibit synthesis and/or release of IL-12 and IFN-(/353%), while rhIL-12 p70 did not augment IFN-g secretion into LPS-stimulated whole blood from critically ill pag, 6,25-28 levels of these cytokines have been determined in LPS-stimulated whole blood from both experimental groups tients (Table 3 , Fig 1C) .
The suppression of the IL-12 IFN-g pathway in whole (Table 5) . Although IL-4 was only detected in minimal amounts in both groups, LPS-induced release of IL-10 blood from critically ill patients was gradually higher in patients with severe sepsis compared with injured patients, (092%) and of TGF-b 1 (054%) was significantly decreased into whole blood from critically ill patients compared with though these differences were not statistically different (Table 4). In contrast, the degree of suppression was not differcontrols (Table 5) .
Effect of preincubation of whole blood with IL-4 or ILent between survivors and nonsurvivors (data not shown).
SAC induced release of IL-12 p40, p70, and IFN-g into 10. To mimic a potential priming effect of IL-4 and IL-10 in vivo with consequent inhibition of secretory capacity of whole blood. To exclude a LPS-specific phenomenon, the release of IL-12 p40, p70, and IFN-g was studied after the PBMC ex vivo, whole blood was preincubated with either rhIL-4 or rhIL-10 in concentrations observed in critically ill addition of SAC. In whole blood from healthy humans, the addition of SAC resulted in a significant secretion of IL-12 patients (Neidhardt et al, manuscript in preparation). was ineffective (Table 6) 
DISCUSSION
The results presented here indicate that the IL-12 IFN-g pathway, which plays a key role in activation of phagocytic cells and of T-cell driven immunity, is significantly compromised in critically ill patients. These results are in line with previous animal experiments that demonstrated a reduced release of IFN-g and IL-12 by splenocytes obtained from burned mice. 29 In whole blood from healthy individuals, IFN-g and IL-12 operate through a positive feedback loop through which IL-12 induces synthesis and release of IFNg and vice versa. This positive feedback mechanism is dramatically inhibited in whole blood obtained from critically ill patients. Monocytes as target cells of IFN-g, as well as TH1-lymphocytes as target cells of IL-12 seem to be deactivated during critical illness with a reduced capacity to synthesize these inflammation upregulating cytokines. Though the pathogenesis of patients with severe injury is different from that of septic patients, the observed defects occur in both groups. The origin of critical illness does not seem to influence these disturbances in the IL-12 IFN-g pathway.
The observed suppression of the IL-12 IFN-g pathway is not specific to LPS, since parallel experiments using SAC as stimulus demonstrated a similar inhibition of IL-12 and IFN-g secretion into whole blood from critically ill patients. Furthermore, experiments using isolated lymphocyte and adherent cell cultures were performed to exclude the possibility that suppression of IL-12 and IFN-g release is due to alterations of differential leukocyte profiles, as they occur during critical illness. 30 These experiments showed similar results than those obtained with whole blood. LPS-induced secretion of IL-12 p40 and p70 by adherent blood cells and IFNg release by lymphocytes were markedly inhibited in critically ill patients compared with healthy individuals. Thus, the suppression of LPS-induced release of IL-12 p40, p70, and IFN-g release into whole blood from critically ill patients seems to be due to intracellular defects of PBMC rather than alterations of their absolute numbers. These observations are in line with our previous findings, which demonstrated that inhibition of LPS-induced proinflammatory cytokine release (TNF-a, IL-1b, IL-6) during severe sepsis (endotoxin tolerance) is related to reduced half-life of cytokine mRNA expression.
14 With regard to the mechanisms of action of suppressed markedly reduce proinflammatory cytokine release and inhibit IL-12, as well as IFN-g synthesis and secretion. 6, 19, [25] [26] [27] [28] 34, 35 When measuring the release of IL-4, IL-10, and TGF-b 1 into LPS-stimulated whole blood, the concentra-AID Heparinized whole blood obtained from healthy individuals (controls, n Å 6) and critically ill patients (n Å 6) was incubated with or without LPS (1 ng/mL) for 24 hours. Plasma levels of IL-4, 10, and TGF-b1 were measured using specific ELISA. Data are presented as mean { SEM.
Abbreviation: ND, not detectable. * P õ .05 patient versus control.
tions of these antiinflammatory reacting cytokines were sigduring critical illness. Preincubation with rhIL-10 resulted in a significant suppression of LPS-induced secretion of ILnificantly decreased in blood from critically ill patients. These results are in line with previous studies indicating 12 p40 and IFN-g. In contrast to rhIL-10, rhIL-4 was ineffective. TGF-b 1 was not tested, since recent studies clearly reduced secretion of IL-10 by PBMC from injured patients and by splenocytes harvested from mice in a trauma-sepsis demonstrated a failure of TGF-b 1 to induce hyporesponsiveness of monocytes to LPS. 35 These data together with model. 36, 37 Though these antiinflammatory reacting mediators do not previous studies 35 indicate that IL-10, but not IL-4 or TGFb 1 , plays a pivotal role in the downregulation of the proinseem to cause suppression of the IL-12 IFN-g pathway ex vivo in whole blood from critically ill patients, recent studflammatory reacting cascade including the IL-12 IFN-g pathway. ies 35 led us to hypothesize that an enhanced release of antiinflammatory mediators in the very early period after trauma
The observation that isolated subpopulations of PBMC (adherent cells, lymphocytes) in contrast to whole blood can or during sepsis may cause deactivation of monocytes and/ or lymphocytes in vivo. This hypothesis was supported by be activated through rhIL-12 p70 to release IFN-g and vice versa implies that additional mechanisms of action may inmeasurements of IL-4 and IL-10 plasma levels in the first 10 hours after injury (Ertel et al, personal communication, hibit the IL-12 IFN-g pathway. The second potential mechanism is based on previous animal experiments and clinical July 1996, data not shown). In this early period after injury, plasma levels of IL-4 and IL-10 were markedly increased studies demonstrating the presence of circulating serum suppressive factors during experimental endotoxemia and after and demonstrated peak levels with decreasing concentrations close to the detection limit thereafter. Most of our whole severe trauma. 32,38 These suppressive proteins may explain two observations of our experiments: (1) the degree of supblood assays of critically ill patients were performed 24 hours after injury or after diagnosis of sepsis. Deactivation pressed IL-12 p40, p70, and IFN-g release in critically ill patients was lower in isolated adherent cell and lymphocyte of monocytes and lymphocytes may already have occurred in vivo during this time period. Moreover, because IL-10 cultures than in whole blood, and (2) isolated adherent cells and lymphocytes responded to rhIFN-g or rhIL-12 p70 with self-limits its own and the synthesis of other antiinflammatory reacting cytokines as an autoregulatory feedback mechaan increased release of IL-12 p70 and IFN-g, which was not observed in whole blood from critically ill patients. These nism, 34, 35 the reduced release of IL-10 and TGF-b 1 observed in LPS-stimulated whole blood from critically ill patients results suggest a potential involvement of circulating proteins, which may suppress secretory capacity of leukocyte may already be caused by desensitization of monocytes in vivo in the first hours after the insult.
subpopulations, especially in the later posttraumatic course. Thus, besides in vivo deactivation and desensitization of The hypothesis of early in vivo deactivation of PBMC is further supported by experiments in which whole blood from PBMC very early during critical illness through antiinflammatory reacting IL-10, the presence of serum suppressive healthy humans was preincubated with either rhIL-4 or rhIL-10, thus mimicking the above described in vivo scenario peptides may contribute to the severe disturbances in the IL- Table 6 . Effect of rhIL-4 and rhIL-10 on Cytokine Secretion by PBMC -/rhIL-4 (1,000 pg/mL) /rhIL-10 (2,500 pg/mL) p40 (pg/mL) IFN-g (pg/mL) p40 (pg/mL) IFN-g (pg/mL) p40 (pg/mL) IFN-g (pg/mL) Exp 1  LPS  106  404  114  430  15  0  Exp 2  LPS  132  410  198  422  36  0  Exp 1  SAC  572  694  618  572  151  378  Exp 2  SAC  251  868  137  704  45  472 Whole blood obtained from healthy individuals (n Å 2) was preincubated with either rhIL-4 (1000 pg/mL) or rhIL-10 (2500 pg/mL) for 12 hours. Thereafter, PBMC were isolated and stimulated with either LPS (1 ng/mL) or SAC (0.075% wt/vol) for 24 hours. Levels of IL-12 p40 and IFN-g in supernatants from PBMC were determined with specific ELISA.
Abbreviation: Exp, experiment.
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